Interdisciplinary framework for adaptive cellular immunity to SARS-CoV-2 | Pandemic PACT Tracker

Key facts

Disease
COVID-19
start year
-99
Known Financial Commitments (USD)
$1,080,000
Funder
Swedish Research Council
Principal Investigator
Marcus Buggert
Research Location
Sweden
Lead Research Institution
Karolinska Institutet
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

Microbiology in the medical field, Infection medicine, Immunology in the medical field

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Identification of soluble biomarkers that associate with distinct manifestations of long COVID.

Effective Prevention and Treatment of Acute Leukemias in Mice by Activation of Thermogenic Adipose Tissues.

Functional SARS-CoV-2 cross-reactive CD4⁺ T cells established in early childhood decline with age.